1 Aapro, M, Launay-Vacher, V, Lichtman, S, et al.JA report from a SIOG Task Force on Renal Safety in the Elderly. SIOG Newsletter 1, 2005.

1 Aapro, M, Launay-Vacher, V, Lichtman, S, et al.JA report from a SIOG Task Force on Renal Safety in the Elderly. SIOG Newsletter1, 2005.)| false
• Search Google Scholar
• Export Citation

2 Al-Sarraf, M, Fletcher, W, Oishi, N et al. 1982 Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study Cancer Treat Rep 66 31–35.

2 Al-Sarraf, M, Fletcher, W, Oishi, N et al. 1982Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group studyCancer Treat Rep6631–35.)| false
• Search Google Scholar
• Export Citation

3 Bálint, P. Az orvosi élettan tankönyve. Medicina, 1974.

3 Bálint, P. Az orvosi élettan tankönyve. Medicina, 1974.)| false
• Search Google Scholar
• Export Citation

4 Brenner, BM, Meyer, TW, Hostetter, TH 1982 Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of glomerular sclerosis in aging, renal ablation, and intrinsic renal disease N Engl J Med 307 652–659.

4 Brenner, BM, Meyer, TW, Hostetter, TH1982Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of glomerular sclerosis in aging, renal ablation, and intrinsic renal diseaseN Engl J Med307652–659.)| false
• Search Google Scholar
• Export Citation

5 Cockcroft, DW, Gault, MH 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31–41.

5 Cockcroft, DW, Gault, MH1976Prediction of creatinine clearance from serum creatinineNephron1631–41.)| false
• Search Google Scholar
• Export Citation

6 Cohen, SH, Abesamis, C, Zangi, I et al. 1977 Body elemental composition: comparison between black and while adults Am J Physiol 232 E119–E122.

6 Cohen, SH, Abesamis, C, Zangi, I et al. 1977Body elemental composition: comparison between black and while adultsAm J Physiol232E119–E122.)| false
• Search Google Scholar
• Export Citation

7 Einhorn, LH, Donohue, J 1977 Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer Ann Intern Med 87 293–298.

7 Einhorn, LH, Donohue, J1977Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancerAnn Intern Med87293–298.)| false
• Search Google Scholar
• Export Citation

8 Garg, AX, Papaioannou, A, Ferko, N et al. 2004 Estimating the prevalence of renal insufficiency in seniors requiring long-term care Kidney Int 65 649–653.

8 Garg, AX, Papaioannou, A, Ferko, N et al. 2004Estimating the prevalence of renal insufficiency in seniors requiring long-term careKidney Int65649–653.)| false
• Search Google Scholar
• Export Citation

9 Greenfeld, Z, Baylis, C. Aging and the renal circulation. In: Advances in Organ Biology, Vol. 9. JAI Press, 2000, pp. 255–274.

9 Greenfeld, Z, Baylis, C.Aging and the renal circulation. In: Advances in Organ Biology, Vol. 9. JAI Press, 2000, pp. 255–274.)| false
• Search Google Scholar
• Export Citation

10 Hayes, DM, Cvitkovic, E, Golbey, RB et al. 1977 High dose cisplatinium diammine dichloride: amelioration of renal toxicity by mannitol diuresis Cancer 39 1372–1381.

10 Hayes, DM, Cvitkovic, E, Golbey, RB et al. 1977High dose cisplatinium diammine dichloride: amelioration of renal toxicity by mannitol diuresisCancer391372–1381.)| false
• Search Google Scholar
• Export Citation

11 Heidemann, HTH, Gerkens, JF, Jackson, EK, Branch, RA 1985 Attenuation of cisplatin induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide Naunyn Schmiedebergs Arch Pharmacol 329 201–205.

11 Heidemann, HTH, Gerkens, JF, Jackson, EK, Branch, RA1985Attenuation of cisplatin induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamideNaunyn Schmiedebergs Arch Pharmacol329201–205.)| false
• Search Google Scholar
• Export Citation

12 Hill, GS 2008 Hypertensive nephrosclerosis Curr Opin Nephrol Hypertens 17 266–270.

12 Hill, GS 2008 Hypertensive nephrosclerosis Curr Opin Nephrol Hypertens 17 266–270.)| false
• Search Google Scholar
• Export Citation

13 Howell, S, Pfeifle, C, Wung, W et al. 1982 Intraperitoneal cisplatin with systemic thiosulfate protection Ann Intern Med 97 845–851.

13 Howell, S, Pfeifle, C, Wung, W et al. 1982Intraperitoneal cisplatin with systemic thiosulfate protectionAnn Intern Med97845–851.)| false
• Search Google Scholar
• Export Citation

14 Hutchinson, FN, Perez, EA, Gandara, DR et al. 1988 Renal salt-wasting in patients treated with cisplatin Ann Intern Med 108 21–25.

14 Hutchinson, FN, Perez, EA, Gandara, DR et al. 1988Renal salt-wasting in patients treated with cisplatinAnn Intern Med10821–25.)| false
• Search Google Scholar
• Export Citation

15 Launay-Vacher, V, Chatelut, E, Lichtman, SM et al. 2007 Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendations Ann Oncol 18 1314–1321.

15 Launay-Vacher, V, Chatelut, E, Lichtman, SM et al. 2007Renal insufficiency in elderly cancer patients: International Society of Geriatric Oncology clinical practice recommendationsAnn Oncol181314–1321.)| false
• Search Google Scholar
• Export Citation

16 Launay-Vacher, V, Etessami, R, Janus, N Renal Insufficiency Anticancer Medications – IRMA – Study Group et al. 2009 Lung cancer and renal insufficiency: prevalence and anticancer drug issues Lung 187 69–74.

16 Launay-Vacher, V, Etessami, R, Janus, NRenal Insufficiency Anticancer Medications – IRMA – Study Group et al. 2009Lung cancer and renal insufficiency: prevalence and anticancer drug issuesLung18769–74.)| false
• Search Google Scholar
• Export Citation

17 Launay-Vacher, V, Izzedine, H, Rey, JB et al. 2004 Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients Med Sci Monit 10 CR209–CR212.

17 Launay-Vacher, V, Izzedine, H, Rey, JB et al. 2004Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patientsMed Sci Monit10CR209–CR212.)| false
• Search Google Scholar
• Export Citation

18 Launay-Vacher, V, Rey, JB, Isnard-Bagnis, C et al. 2008 Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care Cancer Chemother Pharmacol 61 903–909.

18 Launay-Vacher, V, Rey, JB, Isnard-Bagnis, C et al. 2008Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer CareCancer Chemother Pharmacol61903–909.)| false
• Search Google Scholar
• Export Citation

19 Lehane, D, Winston, A, Gray, R, Daskal, Y 1979 The effect of diuretic pretreatment on clinical morphological and ultrastructural cis-platinium induced nephrotoxicity Int J Radiat Oncol Biol Phys 5 1393–1399.

19 Lehane, D, Winston, A, Gray, R, Daskal, Y1979The effect of diuretic pretreatment on clinical morphological and ultrastructural cis-platinium induced nephrotoxicityInt J Radiat Oncol Biol Phys51393–1399.)| false
• Search Google Scholar
• Export Citation

20 Levey, AS, Bosch, JP, Lewis, JB et al. 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 461–470.

20 Levey, AS, Bosch, JP, Lewis, JB et al. 1999A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study GroupAnn Intern Med130461–470.)| false
• Search Google Scholar
• Export Citation

21 Levey, AS, Eckhardt, KU, Tsukamoto, Y et al. 2005 Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 67 2089–2100.

21 Levey, AS, Eckhardt, KU, Tsukamoto, Y et al. 2005Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney Int672089–2100.)| false
• Search Google Scholar
• Export Citation

22 Levey, AS, Greene, T, Kusek, JW, Beck, GJ 2000 A simplified equation to predict glomerular filtration rate from serum creatinine J Am Soc Nephrol 11 155A.

22 Levey, AS, Greene, T, Kusek, JW, Beck, GJ2000A simplified equation to predict glomerular filtration rate from serum creatinineJ Am Soc Nephrol11155A.)| false
• Search Google Scholar
• Export Citation

23 Madias, NE, Harrington, JT 1978 Platinium nephrotoxicity Am J Med 65 307–314.

23 Madias, NE, Harrington, JT1978Platinium nephrotoxicityAm J Med65307–314.)| false
• Search Google Scholar
• Export Citation

24 Marx, GM, Blake, GM, Galani, E et al. 2004 Evaluation of the Cockcroft-Gault, Jelliffe and Wright formulas in estimating renal function in elderly patients Ann Oncol 15 291–295.

24 Marx, GM, Blake, GM, Galani, E et al. 2004Evaluation of the Cockcroft-Gault, Jelliffe and Wright formulas in estimating renal function in elderly patientsAnn Oncol15291–295.)| false
• Search Google Scholar
• Export Citation

25 Máthé, C, Bohács, A, Duffek, L, et al.JCisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients. Eur Respir J erj00551-2010, Epub ahead of print.

25 Máthé, C, Bohács, A, Duffek, L, et al.JCisplatin nephrotoxicity aggravated by cardiovascular disease and diabetes in lung cancer patients. Eur Respir J erj00551-2010, Epub ahead of print.)| false
• Search Google Scholar
• Export Citation

26 Ozols, RF, Ostchega, Y, Myers, CF, Young, RC 1985 High-dose cisplatin in hypertonic saline in refractory ovarian cancer J Clin Oncol 3 1246–1250.

26 Ozols, RF, Ostchega, Y, Myers, CF, Young, RC1985High-dose cisplatin in hypertonic saline in refractory ovarian cancerJ Clin Oncol31246–1250.)| false
• Search Google Scholar
• Export Citation

27 Pera, MF, Jr, Zook, BC, Harder, HC 1979 Effect of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammine platinum (II) in rats Cancer Res 29 1269–1278.

27 Pera, MF, Jr, Zook, BC, Harder, HC1979Effect of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammine platinum (II) in ratsCancer Res291269–1278.)| false
• Search Google Scholar
• Export Citation

28 Perkins, BA, Krolewski, AS 2009 Early nephropathy in type I diabetes: the importance of early renal function decline Curr Opin Nephrol Hypertens 18 233–240.

28 Perkins, BA, Krolewski, AS2009Early nephropathy in type I diabetes: the importance of early renal function declineCurr Opin Nephrol Hypertens18233–240.)| false
• Search Google Scholar
• Export Citation

29 Ries, L, Kosary, C, Hankey, B (eds.) 1998 SEER Cancer Statistics Review, 1975–1995 National Cancer Institute, National Institutes of Health Bethesda, MD.

29 Ries, L, Kosary, C, Hankey, B (eds.) 1998SEER Cancer Statistics Review, 1975–1995National Cancer Institute, National Institutes of HealthBethesda, MD.)| false
• Search Google Scholar
• Export Citation

30 Santoso, JT, Lucci, JA, 3rd, Coleman, RL et al. 2003 Saline, mannitol and furosemide hydration in acute cisplatin nephrotoxicity. A randomized trial Cancer Chemother Pharmacol 52 13–18.

30 Santoso, JT, Lucci, JA, 3rd, Coleman, RL et al. 2003Saline, mannitol and furosemide hydration in acute cisplatin nephrotoxicity. A randomized trialCancer Chemother Pharmacol5213–18.)| false
• Search Google Scholar
• Export Citation

31 Swedko, PJ, Clark, HD, Paramsothy, K, Akbari, A 2003 serum creatinine is an inadequate screening test for renal failure in elderly patients Arch Intern Med 163 356–360.

31 Swedko, PJ, Clark, HD, Paramsothy, K, Akbari, A2003serum creatinine is an inadequate screening test for renal failure in elderly patientsArch Intern Med163356–360.)| false
• Search Google Scholar
• Export Citation

32 Thomas, F, Seronie-Vivien, S, Gladieff, L et al. 2005 Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin Clin Pharmacokinet 44 1305–1316.

32 Thomas, F, Seronie-Vivien, S, Gladieff, L et al. 2005Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatinClin Pharmacokinet441305–1316.)| false
• Search Google Scholar
• Export Citation

33 Verhave, JC, Fesler, P, Ribstein, J et al. 2005 Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index Am J Kidney Dis 46 233–241.

33 Verhave, JC, Fesler, P, Ribstein, J et al. 2005Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass indexAm J Kidney Dis46233–241.)| false
• Search Google Scholar
• Export Citation

34 Yamamoto, K, Shimokawa, T, Yi, H et al. 2002 Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging Am J Pathol 161 1805–1814.

34 Yamamoto, K, Shimokawa, T, Yi, H et al. 2002Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with agingAm J Pathol1611805–1814.)| false
• Search Google Scholar
• Export Citation

35 Yancik, R, Ries, LA 2000 Aging and cancer in America. Demographic and epidemiologic perspectives Hematol Oncol Clin North Am 14 17–23.

35 Yancik, R, Ries, LA2000Aging and cancer in America. Demographic and epidemiologic perspectivesHematol Oncol Clin North Am1417–23.)| false
• Search Google Scholar
• Export Citation